Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
7.43
-0.28 (-3.63%)
At close: Nov 7, 2025, 4:00 PM EST
7.54
+0.11 (1.48%)
After-hours: Nov 7, 2025, 7:41 PM EST

Xeris Biopharma Holdings Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Cash & Equivalents
91.671.6267.45121.9767.2737.6
Upgrade
Short-Term Investments
--5-35.1696.19
Upgrade
Cash & Short-Term Investments
91.671.6272.45121.97102.43133.79
Upgrade
Cash Growth
31.98%-1.15%-40.60%19.07%-23.44%77.09%
Upgrade
Accounts Receivable
53.7540.4239.230.8317.466.88
Upgrade
Receivables
53.7540.4239.230.8317.466.88
Upgrade
Inventory
67.4648.1838.8424.7418.128.35
Upgrade
Prepaid Expenses
11.217.455.789.294.593.2
Upgrade
Total Current Assets
224.02167.66156.26186.82142.6152.21
Upgrade
Property, Plant & Equipment
27.2128.2129.189.516.636.71
Upgrade
Goodwill
22.8622.8622.8622.8622.86-
Upgrade
Other Intangible Assets
90.7998.92109.76120.61131.45-
Upgrade
Other Long-Term Assets
5.325.414.544.730.830.23
Upgrade
Total Assets
370.19323.06322.6344.52304.36159.15
Upgrade
Accounts Payable
6.532.2911.574.618.923.12
Upgrade
Accrued Expenses
81.6156.845.6644.0951.1721.07
Upgrade
Current Portion of Long-Term Debt
-15.1----
Upgrade
Current Portion of Leases
6.196.083.51.58--
Upgrade
Other Current Liabilities
21.8720.1734.4723.3518.954.02
Upgrade
Total Current Liabilities
116.2100.4495.1973.6279.0428.21
Upgrade
Long-Term Debt
219.47217.01190.93187.0888.0787.02
Upgrade
Long-Term Leases
31.9933.2634.769.4--
Upgrade
Long-Term Deferred Tax Liabilities
--2.273.524.94-
Upgrade
Other Long-Term Liabilities
3.391.976.2325.7237.0810.16
Upgrade
Total Liabilities
371.05352.68329.38299.34209.13125.39
Upgrade
Common Stock
0.020.020.010.010.010.01
Upgrade
Additional Paid-In Capital
681.54642.26610.25599.97555.36371.13
Upgrade
Retained Earnings
-682.39-671.86-617.03-554.77-460.11-337.39
Upgrade
Comprehensive Income & Other
-0.03-0.03-0.03-0.02-0.030.01
Upgrade
Total Common Equity
-0.86-29.62-6.7845.1995.2333.76
Upgrade
Shareholders' Equity
-0.86-29.62-6.7845.1995.2333.76
Upgrade
Total Liabilities & Equity
370.19323.06322.6344.52304.36159.15
Upgrade
Total Debt
257.65271.45229.19198.0688.0787.02
Upgrade
Net Cash (Debt)
-166.06-199.83-156.74-76.0914.3746.77
Upgrade
Net Cash Growth
-----69.28%171.21%
Upgrade
Net Cash Per Share
-1.06-1.36-1.14-0.560.181.10
Upgrade
Filing Date Shares Outstanding
165.92153.94140.45137.29135.5259.76
Upgrade
Total Common Shares Outstanding
165.53149.43138.13136.27124.8759.61
Upgrade
Working Capital
107.8267.2261.07113.263.56124.01
Upgrade
Book Value Per Share
-0.01-0.20-0.050.330.760.57
Upgrade
Tangible Book Value
-114.51-151.4-139.41-98.28-59.0833.76
Upgrade
Tangible Book Value Per Share
-0.69-1.01-1.01-0.72-0.470.57
Upgrade
Machinery
6.586.265.655.685.434.32
Upgrade
Leasehold Improvements
5.76.065.985.075.034.63
Upgrade
Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q